{"nct_id":"NCT06280209","title":"A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy","status":"RECRUITING","status_verified_date":"2025-06","start_date":"2024-01-03","start_date_type":"ACTUAL","primary_completion_date":"2026-09-30","primary_completion_date_type":"ESTIMATED","completion_date":"2026-09-30","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["BMRN"]}